| Predictive value of the sFlt-1: PlGF ratio in women with suspected preeclampsia H Zeisler, E Llurba, F Chantraine, M Vatish, AC Staff, M Sennström, ... New England Journal of Medicine 374 (1), 13-22, 2016 | 2141 | 2016 |
| Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia S Rana, CE Powe, S Salahuddin, S Verlohren, FH Perschel, RJ Levine, ... Circulation 125 (7), 911-919, 2012 | 889 | 2012 |
| An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia S Verlohren, A Galindo, D Schlembach, H Zeisler, I Herraiz, MG Moertl, ... American journal of obstetrics and gynecology 202 (2), 161. e1-161. e11, 2010 | 711 | 2010 |
| The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients S Verlohren, I Herraiz, O Lapaire, D Schlembach, M Moertl, H Zeisler, ... American journal of obstetrics and gynecology 206 (1), 58. e1-58. e8, 2012 | 666 | 2012 |
| New gestational phase–specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia S Verlohren, I Herraiz, O Lapaire, D Schlembach, H Zeisler, P Calda, ... Hypertension 63 (2), 346-352, 2014 | 535 | 2014 |
| Implementation of the sFlt-1/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practice H Stepan, I Herraiz, D Schlembach, S Verlohren, S Brennecke, ... Ultrasound in Obstetrics & Gynecology 45 (3), 241, 2015 | 389 | 2015 |
| Visceral periadventitial adipose tissue regulates arterial tone of mesenteric arteries S Verlohren, G Dubrovska, SY Tsang, K Essin, FC Luft, Y Huang, ... Hypertension 44 (3), 271-276, 2004 | 352 | 2004 |
| Clinical interpretation and implementation of the sFlt-1/PlGF ratio in the prediction, diagnosis and management of preeclampsia S Verlohren, SP Brennecke, A Galindo, SA Karumanchi, LB Mirkovic, ... Pregnancy Hypertension 27, 42-50, 2022 | 251 | 2022 |
| Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia S Verlohren, H Stepan, R Dechend Clinical science 122 (2), 43-52, 2012 | 239 | 2012 |
| Clinical characterization and outcomes of preeclampsia with normal angiogenic profile S Rana, WT Schnettler, C Powe, J Wenger, S Salahuddin, AS Cerdeira, ... Hypertension in pregnancy 32 (2), 189-201, 2013 | 215 | 2013 |
| Mechanisms of ADRF release from rat aortic adventitial adipose tissue G Dubrovska, S Verlohren, FC Luft, M Gollasch American Journal of Physiology-Heart and Circulatory Physiology 286 (3 …, 2004 | 206 | 2004 |
| Prediction of preeclampsia-related adverse outcomes with the sFlt-1 (soluble fms-like tyrosine kinase 1)/PlGF (placental growth factor)-ratio in the clinical routine: a real … LA Dröge, FH Perschel, N Stütz, A Gafron, L Frank, A Busjahn, W Henrich, ... Hypertension 77 (2), 461-471, 2021 | 185 | 2021 |
| Hypoxia induces dilated cardiomyopathy in the chick embryo: mechanism, intervention, and long-term consequences A Tintu, E Rouwet, S Verlohren, J Brinkmann, S Ahmad, F Crispi, ... PloS one 4 (4), e5155, 2009 | 178 | 2009 |
| Soluble fms‐like tyrosine kinase‐1 to placental growth factor ratio: ruling out pre‐eclampsia for up to 4 weeks and value of retesting H Zeisler, E Llurba, FJ Chantraine, M Vatish, AC Staff, M Sennström, ... Ultrasound in Obstetrics & Gynecology 53 (3), 367-375, 2019 | 158 | 2019 |
| Uterine artery Doppler, birth weight and timing of onset of pre‐eclampsia: providing insights into the dual etiology of late‐onset pre‐eclampsia S Verlohren, K Melchiorre, A Khalil, B Thilaganathan Ultrasound in Obstetrics & Gynecology 44 (3), 293-298, 2014 | 157 | 2014 |
| Update on the diagnosis and prognosis of preeclampsia with the aid of the sFlt-1/PlGF ratio in singleton pregnancies I Herraiz, E Llurba, S Verlohren, A Galindo, ... Fetal diagnosis and therapy 43 (2), 81-89, 2018 | 152 | 2018 |
| Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age–matched case study F Herse, S Verlohren, K Wenzel, J Pape, DN Muller, S Modrow, ... Hypertension 53 (2), 393-398, 2009 | 146 | 2009 |
| Circulating angiogenic factors and risk of adverse maternal and perinatal outcomes in twin pregnancies with suspected preeclampsia S Rana, MR Hacker, AM Modest, S Salahuddin, KH Lim, S Verlohren, ... Hypertension 60 (2), 451-458, 2012 | 139 | 2012 |
| Characterization of the soluble fms-like tyrosine kinase-1 to placental growth factor ratio in pregnancies complicated by fetal growth restriction I Herraiz, LA Dröge, E Gómez-Montes, W Henrich, A Galindo, S Verlohren Obstetrics & Gynecology 124 (2 PART 1), 265-273, 2014 | 138 | 2014 |
| A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre‐eclampsia: Compiled by the Pregnancy and Non … LC Poon, LA Magee, S Verlohren, A Shennan, P von Dadelszen, ... International Journal of Gynecology & Obstetrics 154, 3-31, 2021 | 132 | 2021 |
Prof. Dr. Wolfgang HenrichCharite - BerlinVerified email at med.wayne.edu
